Genesis Reports $3 Million Financing for Chinese Partner Company


BEIJING, March 1, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTCBB:GTEC) announced that Lotus Pharmaceuticals, Inc. (OTCBB:LTUS) has completed a $3 million financing with a U.S.-based investment fund. The Beijing-based pharmaceutical company is a graduate of the Genesis growth and capital program, which operates under the subsidiary name, Genesis Equity Partners, LLC ("GEP").

Dr. Liu Zhongyi, Lotus CEO, commented: "This $3 million investment provides Lotus with additional capital resources to better deploy and expand our product line, improve our balance sheet and execute our strategic business plan that is focused on marketing, acquisitions and corporate development. We are grateful for the guidance provided by our partner, GEP. Genesis's dedication and leadership assisted our transformation and impressively increased the value of Lotus. This initial funding is the beginning for Lotus, as Western capital will enable our Company to establish a presence first nationally, then internationally amongst China-based pharmaceuticals."

Dr. Shaohua Tan, Genesis Director in China, observed: "The GEP program should significantly strengthen Genesis' profit-earning capability over the long run. Indeed, the large majority of 2006 income of the Company came from only one partnering company, Lotus Pharmaceuticals. We have now signed up three additional companies, with expected project completion dates in the foreseeable future, possibly in this calendar year. What's more, Genesis believes that it could be able to qualify and sign up as many as six new partnering Chinese companies over the next 12-18 months, which could put Genesis on the fast-growth track for years to come."

About Genesis Technology Group, Inc.

Genesis Technology Group, Inc. (d/b/a Genesis China and GTEC) is a U.S. public company that earns, enhances and markets equity positions in small to mid-sized Chinese enterprises. Commitment, dedication, and expertise are the key components to the Genesis "Mission Statement." It has created a successful profit center by incubating Chinese companies in a wide range of sectors, creating so-coined "partner companies." Genesis makes a long-term commitment with management consultation, board of directors composition, creation and implementation of successful business models, which include expansion of markets in China and abroad. To help drive the success and profitability of these operations, Genesis provides resources and proficiency to maximize partners' leadership potential in China and attempts to increase high-margin, predictable earnings. For more information, visit http://www.Genesis-China.net.

Safe Harbor Statement and Disclaimer

Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission. The capital and growth program, the Company's central profit center, has specific risks and liabilities. Followers of our business model must understand that, until the Chinese partner company officially reaches public company status and files its initial Form 8-K, a high degree of risk exists that the partner may not ever attain that status. While receipt of a significant equity position in these companies is contractual, Genesis still recognizes that such compensation is conditional on performance and specific deliverables.



            

Contact Data